Fuso Pharmaceutical Industries,Ltd.

TSE:4538.T

2203 (JPY) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

20232022202120202019201820172016201520142013201220112010200920082007200620052004
Revenue 55,40751,01549,63249,25346,90146,07345,90046,78145,75247,04249,10048,61244,35847,46946,56045,90143,99143,16942,67241,938
Cost of Revenue 41,88937,27436,23535,14134,10032,64432,62933,53233,20134,04634,41933,29632,16433,65932,66232,05931,35030,00528,91628,192
Gross Profit 13,51813,74113,39714,11212,80113,42913,27113,24912,55112,99614,68115,31612,19413,81013,89813,84212,64113,16413,75613,746
Gross Profit Ratio 0.2440.2690.270.2870.2730.2910.2890.2830.2740.2760.2990.3150.2750.2910.2980.3020.2870.3050.3220.328
Reseach & Development Expenses 1,4691,3531,4421,4621,4091,7642,0052,0912,084001,6731.739003,6852,9642,4192,6311,948
General & Administrative Expenses 000000000007,6367.647002,6342,6482,6492,6812,674
Selling & Marketing Expenses 000000000001,9702.084013,43400000
SG&A 10,0849,8019,5449,8119,8759,9019,9739,9519,772009,6069.731013,4342,6342,6482,6492,6812,674
Other Expenses -1-36474121126-5314420463125-42-1731562424774-33
Operating Expenses 11,55311,53311,47311,76011,79012,16812,47112,59312,25412,19911,88411,49911,71311,63913,4349,1018,4137,9278,3017,752
Operating Income 1,9652,2061,9242,3511,0101,2617986562967962,7973,8164802,169463296-4396048611,386
Operating Income Ratio 0.0350.0430.0390.0480.0220.0270.0170.0140.0060.0170.0570.0780.0110.0460.010.006-0.010.0140.020.033
Total Other Income Expenses Net -198-1-13-731-7563405-180-145-1482,420-475-1,187109-4,892-4,182-6,643-7,507-4,904
Income Before Tax 1,7672,2051,9112,3451,0421,2551,3611,0611176522,6496,2376984573-15146-1,406-2,0521,090
Income Before Tax Ratio 0.0320.0430.0390.0480.0220.0270.030.0230.0030.0140.0540.12800.0210.012-0.0030.001-0.033-0.0480.026
Income Tax Expense 3895994277373353613912001073116701,365-365-16054779-60632-122507
Net Income 1,3771,6051,4831,607707894970861103401,9794,8713721,144518-931107-2,038-1,929582
Net Income Ratio 0.0250.0310.030.0330.0150.0190.0210.01800.0070.040.10.0080.0240.011-0.020.002-0.047-0.0450.014
EPS 159.92182.99169.05183.1680.57101.86109.695.861.1237.7218.7538.141.1126.457.3-102.7111.8-224.51-212.3161.7
EPS Diluted 159.92182.99169.05183.1680.57101.86109.695.861.1237.7218.7538.141.1126.457.3-102.7111.8-224.51-212.3161.7
EBITDA 3,6954,7444,6104,8433,6033,4452,9102,8251,8512,7724,7175,5982,3314,0942,7156,9796,5197,7647,5318,940
EBITDA Ratio 0.0670.0930.0930.0980.0770.0750.0630.060.040.0590.0960.1150.0530.0860.0580.1520.1480.180.1760.213